Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

Did you know that 90% of a child’s brain is developed by the age of 5? During this critical window, parents act as the first, and perhaps, most influential teachers, and one of the best ways to embrace this role is to read to your child.

“Story time” is a fond memory for many of us – snuggling up on a parent’s lap and being transported to another world. Little did we know how much we were actually learning at the same time. Books teach us about the world around us, fire up our imagination and help us relate to the experiences of the characters within them.

Making Playtime a Learning Experience

Establishing a love for reading also sets your child up for long-term success. While the myth about using calculus or chemistry in your everyday life may not have come true, reading and writing are fundamental skills that come in handy no matter what your child goes on to accomplish.

Start the intellectual development early. Take the time to read with your child every day. Snuggle up with a book to help them wind down for bed. Once they’re old enough, point to the words as you read and sound them out. Practice throughout the day by pointing out street signs or labels on household products. Not only will you be working on their language abilities, you’ll be spending fun, rewarding and effective quality time together.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.